Activity‐based costs of blood transfusions in surgical patients at four hospitals

Transfusion - Tập 50 Số 4 - Trang 753-765 - 2010
Aryeh Shander1,2,3,4,5, Axel Hofmann1,2,3,4,5, Sherri Ozawa1,2,3,4,5, Oliver M. Theusinger1,2,3,4,5, H. Gombotz1,2,3,4,5, Donat R. Spahn1,2,3,4,5
1From The Institute for Patient Blood Management and Bloodless Medicine at Englewood Hospital and Medical Center, Englewood, New Jersey
2the Department of Anesthesiology and Intensive Care, General Hospital, Linz, Austria.
3the Department of Anesthesiology, University Hospital Lausanne, Lausanne, Switzerland
4the Institute of Anesthesiology, University Hospital Zurich, Zurich, Switzerland
5the Medical Society for Blood Management, Laxenburg, Austria

Tóm tắt

BACKGROUND: Blood utilization has long been suspected to consume more health care resources than previously reported. Incomplete accounting for blood costs has the potential to misdirect programmatic decision making by health care systems. Determining the cost of supplying patients with blood transfusions requires an in‐depth examination of the complex array of activities surrounding the decision to transfuse.

STUDY DESIGN AND METHODS: To accurately determine the cost of blood in a surgical population from a health system perspective, an activity‐based costing (ABC) model was constructed. Tasks and resource consumption (materials, labor, third‐party services, capital) related to blood administration were identified prospectively at two US and two European hospitals. Process frequency (i.e., usage) data were captured retrospectively from each hospital and used to populate the ABC model.

RESULTS: All major process steps, staff, and consumables to provide red blood cell (RBC) transfusions to surgical patients, including usage frequencies, and direct and indirect overhead costs contributed to per‐RBC‐unit costs between $522 and $1183 (mean, $761 ± $294). These exceed previously reported estimates and were 3.2‐ to 4.8‐fold higher than blood product acquisition costs. Annual expenditures on blood and transfusion‐related activities, limited to surgical patients, ranged from $1.62 to $6.03 million per hospital and were largely related to the transfusion rate.

CONCLUSION: Applicable to various hospital practices, the ABC model confirms that blood costs have been underestimated and that they are geographically variable and identifies opportunities for cost containment. Studies to determine whether more stringent control of blood utilization improves health care utilization and quality, and further reduces costs, are warranted.

Từ khóa


Tài liệu tham khảo

10.1016/j.tmrv.2004.09.005

10.1046/j.1537-2995.1991.31491213295.x

10.1200/JCO.1998.16.7.2364

10.1056/NEJM199503163321106

10.1200/JCO.2000.18.14.2755

10.1046/j.1537-2995.1995.35595259154.x

10.1016/0002-9343(93)90086-5

10.1046/j.1537-2995.2000.40091063.x

10.1046/j.1537-2995.2002.00022.x

Wayne AS, 2000, Financial analysis of chronic transfusion for stroke prevention in sickle cell disease, Blood, 96, 2369, 10.1182/blood.V96.7.2369

Grimm AM, 1989, Economics of epoetin therapy, Clin Pharm, 8, 807

10.1016/S0272-6386(12)80258-7

10.1111/j.1537-2995.2007.01286.x

United States Department of Labor Bureau of Labor Statistics.Consumer price index inflation calculator. [cited 2009 Jun 19]. Available from: URL:http://www.bls.gov/data/inflation_calculator.htm

10.1016/j.bpa.2007.01.002

10.1046/j.1537-2995.43.8s.2.x

Asadi MJ, 1996, Activity‐based costing for clinical paths. An example to improve clinical cost & efficiency, J Soc Health Syst, 5, 1

10.1177/108925320500900106

10.1016/j.atc.2005.02.002

New Jersey Department of Health and Senior Services, Health Care Quality Assessment Office of the Commissioner, 2009, Cardiac surgery in New Jersey 2006. Report 1401

10.1016/j.athoracsur.2008.10.044

Blumberg N, 1997, Allogeneic transfusion and infection: economic and clinical implications, Semin Hematol, 34, 34

Sazama K, 2000, Practice parameter for the recognition, management, and prevention of adverse consequences of blood transfusion, Arch Pathol Lab Med, 124, 61, 10.5858/2000-124-0061-PPFTRM

10.1056/NEJM199902113400606

10.1001/archinte.153.9.1107

Hellinger FJ, 1993, The lifetime cost of treating a person with HIV, JAMA, 270, 474, 10.1001/jama.1993.03510040078033

10.1046/j.1537-2995.1999.39080808.x

10.7326/0003-4819-122-9-199505010-00004

10.1046/j.1537-2995.1999.39070694.x

10.1007/s001340050709

10.1136/bmj.319.7201.16

10.1054/blre.2001.0151

10.1016/S0002-9610(99)80054-3

Dodd RY, 1994, Blood supply: risks, perceptions and prospects for the future, 1

10.1001/jama.287.15.1968

10.1056/NEJM199606273342601

10.1046/j.1537-2995.1990.30790385515.x

Sazama K, 1994, Bacteria in blood for transfusion: a review, Arch Pathol Lab Med, 118, 350

10.1097/00005373-199911000-00018

10.1097/00062752-199811000-00008

10.1046/j.1423-0410.2002.00198.x

Denton TA, 1994, Anemia therapy: individual benefit and societal cost, Semin Oncol, 21, 29

Barnett A, 2002, Anemia‐related costs for cancer patients, J Manag Care Med, 6, 20

United States Department of Health & Human Services.2007 National Blood Collection and Utilization Survey Report. [cited 2009 Jun 19]. Available from: URL:http://www.hhs.gov/ophs/bloodsafety/2007nbcus_survey.pdf

10.1177/003591576505800503

Thông tin
Thông tin xuất bản

Transfusion

Tập 50 Số 4

753-765

Thông tin tác giả